Immunomodulatory therapy of recurrent purpura associated with Sjögren's syndrome. Effect of oral gold compound.
Katayama
I
I
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D005260:Female; D006046:Gold / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011693:Purpura / Q000150:complications* / Q000188:drug therapy*; D012008:Recurrence; D012859:Sjogren's Syndrome / Q000150:complications*
D000276:Adjuvants, Immunologic; D006046:Gold